Heart Failure
136 - 150 of
234 Results
Sort Results:
Article:
The Avandia (rosiglitazone) debate will heat up again now that FDA will loosen its restrictions
January 2014
Commentary:
FDA to Lift Some Avandia (Rosiglitazone) Prescribing/Dispensing Restrictions
January 2014
Article:
Experts will debate whether gliptins (Onglyza, etc) increase cardiovascular risk in patients with type 2 diabetes
November 2013